Yeast-Based Drug Discovery


The humanized yeast model has emerged as a powerful tool in large-scale screenings directed to target human proteins. The high degree of cellular processes conservation between the yeast Saccharomyces cerevisiae and higher eukaryotes has made this microorganism a valuable cell model to study the pathobiology of several human diseases.  The yeast target-based approach can be highly useful in the first-line screening of potentially active compounds to be tested in more complex cell models.


    Related Conference of Yeast-Based Drug Discovery

    July 03-04, 2023

    15th International Virology Summit

    London, UK
    July 10-11, 2023

    8th International Conference on Bacteriology

    Valencia, Spain
    July 26-27, 2023

    29th Global Summit on Bioinformatics

    Montreal, Canada
    August 17-18, 2023

    4th International Conference on Molecular Microbiology

    Dublin, Ireland
    October 25-26, 2023

    10th World Congress on Microbiology & Infectious Diseases

    Zurich, Switzerland
    November 13-14, 2023

    11th Global Medical Microbiology Summit & Expo

    Edinburgh, Scotland
    November 15-16, 2023

    11th World Congress and Expo on Applied Microbiology

    Barcelona, Spain
    November 20-21, 2023

    6th World Congress on Virology and Diseases Control

    London, UK
    November 27-28, 2023

    6th Global Summit on Microbiome

    Budapest, Hungary
    December 04-05, 2023

    23rd Global Conference on Gerontology

    Venice, Italy
    December 15-16, 2023

    27th World Congress on Biotechnology

    Amsterdam, Netherlands

    Yeast-Based Drug Discovery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in